Main Street Research’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-44,426
| Closed | -$4.65M | – | 98 |
|
|
2015
Q4 | $4.65M | Sell |
44,426
-745
| -2% | -$78K | 0.99% | 42 |
|
|
2015
Q3 | $5.29M | Sell |
45,171
-42,186
| -48% | -$4.94M | 1.24% | 32 |
|
|
2015
Q2 | $11.9M | Buy |
87,357
+1,663
| +2% | +$227K | 2.45% | 3 |
|
|
2015
Q1 | $10.7M | Buy |
85,694
+1,785
| +2% | +$222K | 2.3% | 5 |
|
|
2014
Q4 | $7.59M | Buy |
83,909
+2,670
| +3% | +$241K | 1.62% | 20 |
|
|
2014
Q3 | $5.86M | Buy |
81,239
+5,515
| +7% | +$398K | 1.31% | 29 |
|
|
2014
Q2 | $4.71M | Buy |
75,724
+2,925
| +4% | +$182K | 1.11% | 35 |
|
|
2014
Q1 | $4.97M | Buy |
72,799
+12,424
| +21% | +$848K | 1.21% | 31 |
|
|
2013
Q4 | $4.25M | Buy |
60,375
+1,527
| +3% | +$107K | 1.06% | 37 |
|
|
2013
Q3 | $4.25M | Buy |
58,848
+7,913
| +16% | +$571K | 1.15% | 36 |
|
|
2013
Q2 | $2.84M | Buy |
+50,935
| New | +$2.84M | 0.86% | 42 |
|